Spirogen
Spirogen is a clinical stage biotechnology company specialising in novel, sequence-selective, DNA minor groove-binding molecules with
Based based in Europe, Middle East, and Africa (EMEA), Spirogen works in biotechnology, health care, medical, founded in 2000.
As a business in biotechnology, health care, medical, Spirogen is listed here with the public details available about it.
Europe, Middle East, and Africa (EMEA) is where the company is located.
It is recorded at the Private_Equity stage.
Recorded headcount: c_00101_00250 employees.
Public records show total funding of about $16.4M.
| Sector | Biotechnology, Health Care, Medical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2000 |
| Employees | c_00101_00250 |
| Stage | private_equity |
| Total funding | $16,433,998 |
Website: spirogen.com
Sign in to view the contact information we hold for Spirogen.
Create a free account
Create a free account